“A lot of what’s happening in CFS is probably not happening in the blood.” Amy Proal If we’re going to get to the promised land, it’s probably going to come through better technology – which is a good thing – as technological...
A rough winter awaits. Did we relax our vigilance too soon? Eric Topol started off his latest article, “The new COVID wave”, stating “Things are once again going in the wrong direction in the United States.” (What else is new?) Walk into a...
What’s a potential medical breakthrough without a little controversy? Resia Pretorius Ph.D., a South African researcher from the Stellenbosch University in South Africa, and her colleague Douglas Kell from the University of Liverpool, UK, are right in the thick...
Suzanne Vernon’s interest in pathogens and post-infectious diseases goes back to when, as a 20-year-old, she landed a work-study job at the CDC’s Division of Vector-Borne Diseases while an undergraduate at Colorado State University. Ten years later with...
It’s nice to have a billionaire in your corner. Earlier this year, billionaire Vitalik Buterin pledged to devote $100 million to high-risk, high-reward COVID-19 efforts. He made good on at least $15 million of that when he jumpstarted The Long COVID...